Strbac Miroslav, Popović Lidija, Jović Milena, Ilić Srbislav, Dimitrijević Jovan
Vojnomedicinska akademija, Zavod za patologiju i sudsku medicinu, Beograd.
Vojnosanit Pregl. 2002 Nov-Dec;59(6 Suppl):99-102.
Azzopardi and Eusebi were the first to describe pigmented breast cancers in 1977. They postulated that the mammary cancer might become colonized by melanocytes at the expense of the epidermis, which was focally depleted of melanocytes, and that it occurred in most cases of breast cancers in which tumor cells reached the dermal-epidermal interface. Other authors suggested melanocytic differentiation of tumor cells. In this paper a case of a patient with ductal invasive breast cancer with partial melanocytic differentiation was presented, documented by HMB-45 and melan-A reactivity of tumor cells. Tumor was positive with antibodies for estrogen and progesterone receptors, pancytokeratin, negative with antibodies for S-100 protein and vimentin. Masson-Fontana reaction was negative. It was concluded that pigmented tumors should be differentiated from tumors with partial melanocytic differentiation, and that clinical significance of melanocytic differentiation should be analysed on larger number of cases.
阿佐帕迪和尤塞比于1977年首次描述了色素沉着性乳腺癌。他们推测,乳腺癌可能会以表皮黑素细胞局部缺失为代价,被黑素细胞定植,且这种情况发生在大多数肿瘤细胞到达真皮 - 表皮界面的乳腺癌病例中。其他作者则提出肿瘤细胞的黑素细胞分化。本文报告了1例具有部分黑素细胞分化的导管浸润性乳腺癌患者,肿瘤细胞的HMB - 45和黑素A反应性证明了这一点。肿瘤对雌激素和孕激素受体、全细胞角蛋白抗体呈阳性,对S - 100蛋白和波形蛋白抗体呈阴性。马森 - 丰塔纳反应为阴性。得出的结论是,色素沉着性肿瘤应与具有部分黑素细胞分化的肿瘤相鉴别,并且黑素细胞分化的临床意义应在更多病例中进行分析。